Nils Lonberg

Humankind vs. Cancer: The Scorecard

Jonathan Simons, Chris Boshoff, André Choulika, Carlo Greco, Nils Lonberg, Richard Paulson, Suzanne Topalian

Leading oncologists and industry executives convened to address the global burden of nine million annual cancer deaths by highlighting transformative breakthroughs in CAR T-cell therapy, immune checkpoint inhibitors, and precision medicine. Panelists emphasized that reducing mortality rates requires harmonizing clinical trial consent rules, shifting from empirical chemotherapy to rational drug combinations, and leveraging advanced ex vivo models to accelerate development. The consensus call to action urges a unified global strategy prioritizing early detection, patient access to novel innovations, and the removal of intellectual property barriers to eliminate the human and economic costs of cancer.